Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial (Q34645599)
scientific article
Language:
Current Data About Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
(P31) (Q13442814)
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P50) (Q37068027)
(P1545) 6
(P1932) Eric Van Cutsem

(Q56250413)
(P1932) Thierry André
(P1545) 16

(Q54285507)
(P1932) Dirk Arnold
(P1545) 3

(Q42843450)
(P248)

(P304) 29-37
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P433) 1
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P478) 14
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P577) Friday, November 16, 2012
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P921) (Q42824827)

(Q188874)
(P887)

(Q413299)
(P887)

(Q108566365)
(P887)

(Q25493920)
(P887)

(P1433) (Q13747613)
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P1476) "Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial" (language: en)
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P2093) Jaafar Bennouna
(P1545) 1
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Javier Sastre
(P1545) 2
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Pia Österlund
(P1545) 4
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Richard Greil
(P1545) 5
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Roger von Moos
(P1545) 7
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Jose Maria Viéitez
(P1545) 8
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Olivier Bouché
(P1545) 9
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Christophe Borg
(P1545) 10
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Claus-Christoph Steffens
(P1545) 11
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Vicente Alonso-Orduña
(P1545) 12
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Christoph Schlichting
(P1545) 13
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Irmarie Reyes-Rivera
(P1545) 14
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Belguendouz Bendahmane
(P1545) 15
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

Stefan Kubicka
(P1545) 17
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

ML18147 Study Investigators
(P1545) 18
(P248)
(P698) 23168366
(P813) Thursday, August 3, 2017

(P2860) (Q27860681)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q34590731)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q33389870)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q56679480)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q43281857)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q46029883)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q28189472)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q29616236)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q34624122)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q44078747)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q35753569)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q24561642)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q82294729)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q43910377)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q29396936)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q37079652)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q24608005)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q34642136)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

(Q34530109)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970477-1
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S1470-2045(12)70477-1
(P698) 23168366